The Overdose Response Strategy (ORS) is an unprecedented and unique public health-public safety partnership between the Office of National Drug Control Policy (ONDCP) and the U.S. Centers for Disease Control and Prevention (CDC) through their support of the High Intensity Drug Trafficking Areas (HIDTA) program and the CDC Foundation. At its core, the ORS is an example of a cross-agency, interdisciplinary collaboration with a single mission of reducing overdose deaths and saving lives across the United States.
WHO WE ARE
The ORS, a partnership between CDC and ONDCP, with support from HIDTA and the CDC Foundation, has grown tremendously since its inception. The program began in 2015 with only five originating HIDTAs, covering 15 states. Today, the program includes all 33 HIDTAs, covering 50 states, Puerto Rico and the U.S. Virgin Islands.
…the importance of public health and safety partnerships like the Overdose Response Strategy [is] to help us meet people where they are in order to save lives…
WHAT WE DO
Tribal communities have been facing issues with access to care and treatment, especially with opioids and other drug threats impacting their tight-knit communities. To provide these communities with attainable treatment
In collaboration with the Mississippi State Department of Health, the Mississippi (MS) ORS team develops products to inform public health and public safety groups on how to best allocate overdose
The North Florida ORS team regularly partners with key stakeholders to raise drug-related awareness and reduce substance use and overdose. Due to the lack of fentanyl awareness within the team’s
Aiming to increase access to medications for opioid use disorder (MOUD) and reduce overdose deaths, the Maryland (MD) ORS team serves as part of a coalition of stakeholders working to